Survival and Toxicity of an Allogeneic Cytokine-secreting Fibroblast Vaccine in the Central Nervous System
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
1987 • 64,270 citations
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
1987 • 45,673 citations
T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for Activity
1978 • 3,314 citations
A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
1987 • 2,769 citations
Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor
1978 • 1,284 citations
Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2
1994 • 1,070 citations
National survey of patterns of care for brain-tumor patients
1989 • 385 citations
Unraveling Immune Privilege
1995 • 302 citations
Intratumoral LAK cell and interleukin-2 therapy of human gliomas
1989 • 252 citations
Rejection of mouse sarcoma cells after transfection of MHC class II genes.
1990 • 171 citations
Treatment of glioma by engineered interleukin 4-secreting cells.
1993 • 149 citations
Induction in a murine tumor of immunogenic tumor variants by transfection with a foreign gene.
1988 • 110 citations
RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
1995 • 107 citations
Retroviral expression of the human IL-2 gene in a murine T cell line results in cell growth autonomy and tumorigenicity.
1987 • 103 citations
In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors
1994 • 87 citations
Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes
1990 • 80 citations
Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene.
1989 • 76 citations
Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-?. Results of a phase I clinical trial
1992 • 75 citations
Prolonged survival of mice with glioma injected intracerebrally with double cytokine—secreting cells
1995 • 70 citations
Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes
1992 • 51 citations
MANIPULATION OF METASTASIS AND TUMOUR GROWTH BY TRANSFECTION WITH HISTOCOMPATIBILITY CLASS I GENES
1986 • 47 citations
Immunity to B16 melanoma in mice immunized with IL‐2‐secreting allogeneic mouse fibroblasts expressing melanoma‐associated antigens
1992 • 44 citations
Partial suppression of anchorage-independent growth and tumorigenicity in immunodeficient mice by transfection of the H-2 class I gene H-2Ld into a human colon cancer cell line (HCT).
1988 • 26 citations
Immunity to melanoma in mice immunized with transfected allogeneic mouse fibroblasts expressing melanoma-associated antigens
1991 • 6 citations
Cited By (0)
No citing papers found in database